Rocket Lab’s Rocket Production Is Ramping Up — But the Stock Is Sinking
Published on 07/17/2026 at 18:24 | Redaktion boerse-global.de
Rocket Lab has hit a manufacturing milestone that would make most industrial startups envious: it can now roll out a fully assembled Electron rocket every 11 days. That assembly-line tempo is designed to support a growing launch manifest that includes two fresh NASA science missions and a contract for the US Space Force. On the factory floor, the company appears to be executing with precision. On the trading floor, the picture could hardly be more different.
The stock closed Thursday at €59.10, a level that represents a 55.8% plunge from its 52-week high of €133.80 set on May 27. The slide has been sharp enough to push the Relative Strength Index to 30.5, a reading that technicians classify as deeply oversold. Investors who have watched the equity tumble 36.4% in the past month alone are now grappling with a market capitalisation of roughly €44.4 billion — a number that looks increasingly disconnected from the company’s operational progress.
The latest leg lower was triggered on July 16, when Piper Sandler initiated coverage with a neutral rating and a $83 price target, arguing that Rocket Lab looks expensive relative to SpaceX and that AST SpaceMobile is the better space-sector bet at its $100 target. The stock reeled more than 11% that day, touching its lowest level in months. Adding to the pressure was news that CEO Peter Beck had sold $110 million of his own shares, a move several market watchers flagged as a warning signal.
At the heart of the investor unease lies Rocket Lab’s ambitious $8 billion acquisition of Iridium Communications, a deal CEO Beck has described as the cornerstone of a “self-starting space superpower.” The financing package includes a $3.6 billion bridge loan, and the prospect of dilution has unnerved shareholders. The anxiety was compounded when AST SpaceMobile issued a second $1 billion convertible note, triggering a sector-wide rout that erased roughly 10.3% from space stocks including Rocket Lab, Redwire and Intuitive Machines in a single session. Analysts noted that the Iridium deal, while strategically compelling, exposes Rocket Lab to the kind of balance-sheet scrutiny that growth-stage investors rarely tolerate.
Should investors sell immediately? Or is it worth buying Rocket Lab?
Amid the financial noise, the company’s underlying business continues to generate headlines of a more constructive sort. The NASA contract disclosed this week awards Rocket Lab two Electron missions — PolSIR, which will study ice clouds in tropical and subtropical regions via two separate launches as early as June 2027, and TSIS-2, slated for early 2027 to measure total solar energy reaching Earth. The missions fall under a broader contract vehicle that could be worth up to $300 million over ten years. Rocket Lab is also flying the LOXSAT-1 mission for NASA and Eta Space from its New Zealand launch site, testing 11 technologies for cryogenic fuel management that could underpin future orbital fuel depots.
The commercial pipeline looks solid too. Second-quarter revenue clocked in at $200.3 million, a 63% year-over-year jump, and the backlog expanded 20% to $2.2 billion. On the development side, the larger Neutron rocket is on track for five dedicated flights, and the Archimedes vacuum engine test was completed successfully. Rocket Lab also secured a contract for the VICTUS-HAZE mission for the US Space Force, adding to a tally of more than 90 Electron missions flown to date.
Wall Street is split on whether those achievements justify the recent sell-off. Morgan Stanley has maintained its overweight rating with a $105 target and even raised its bull-case scenario to $293 following the Iridium deal. Bank of America and Citi are similarly bullish with $110 and outperform ratings respectively, while Roth and Citizens each see $130. The consensus price target on TipRanks stands at $111.40, with a “Strong Buy” rating — making Piper Sandler’s neutral call the outlier in an otherwise optimistic analyst pack.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
From a technical perspective, traders are watching a support zone between $63.70 and $66.73 (roughly €58-€61) that was tested on July 17. Analysts at wallstreetONLINE note that while short-term signals are bearish, the longer-term Elliott wave structure remains constructive. Whether the stock can stabilise at these levels or extend its decline will likely be determined in the coming sessions — a period that promises to be especially volatile given the sector’s recent turbulence and the sheer speed at which Rocket Lab’s share price has fallen.
Ad
Rocket Lab Stock: New Analysis - 17 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
